Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cephalon executives to join Arana board

This article was originally published in Scrip

Executive Summary

Four senior Cephalon executives have joined the board of Arana Therapeutics, following Cephalon's acquisition of a majority holding in the Australian antibody firm. They are chairman and CEO Dr Frank Baldino Jr, chief financial officer Kevin Buchi, chief scientific officer Dr Jeffry Vaught and chief medical officer Dr Lesley Russell. Dr Baldino has been appointed chairman to succeed Robin Beaumont, who will step down to become lead independent director. Gordon Black and Lincoln Chee have retired as non-independent directors from Arana's board.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC002286

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel